Innovation

China’s First DHI Bleeding Point Detection Technology
DHI uses narrow-band green and red light illumination, combined with algorithmic analysis of hemoglobin concentration differences, to rapidly locate bleeding points in the presence of blood. It significantly improves the efficiency and safety of endoscopic hemostasis, addressing a longstanding gap in China’s domestically developed imaging solutions for therapeutic endoscopy.

Industry-First Large-Channel Optical Magnifying Gastroscope
The EG-12ZT combines 145× optical magnification with a 3.2 mm large therapeutic channel. Once a lesion is identified during detailed examination, treatment can proceed immediately without changing endoscopes, significantly shortening procedure time and reducing intraoperative risk.

Industry-First Ultra-Slim Gastroscope with Water Jet
With a distal-end outer diameter of just 5.4 mm, the EG-12NT significantly improves ease of insertion and patient comfort. Its integrated water jet expands the indications for endoscopic procedures, making a wider range of complex endoscopic interventions possible.

Full-Scenario Special Light Imaging
Four imaging modes—HLI (High Color Restored White Light Imaging), TCI (Tissue Color Differentiation Emphasis Imaging), SVI (Superficial Vascular Emphasis Imaging), and DHI (Deep Vessel Emphasis and Hemorrhage Source Imaging)—target different depths of mucosal tissue, enabling efficient applications across the entire clinical pathway, from detection and diagnosis to treatment.

High-Fidelity All-Electronic Signal Architecture
High-speed, fully electronic signal transmission eliminates the need for costly fiber-optic solutions while delivering high bandwidth, strong interference resistance, and real-time lossless image transmission. It provides stable and reliable support for 4K UHD endoscopic imaging in complex clinical environments.

Safer Care Through Continuous Innovation
Guided by unmet clinical treatment needs, we continue to advance core technologies, optimize endoscope design and imaging modes, and develop innovative products that help physicians deliver more precise and efficient treatment.

Full-Scenario Coverage Across Multiple Specialties
Extending from gastroenterology to pulmonology, urology, and beyond, we are building a differentiated portfolio of flexible endoscopes covering the entire clinical pathway from screening and diagnosis to treatment. The portfolio addresses tiered clinical needs, from primary hospitals to leading tertiary medical centers.

AI-Assisted Diagnosis and Treatment
We are developing deep learning-based algorithms for automatic lesion detection, bowel preparation quality scoring, and blind-spot monitoring. By highlighting suspicious areas and assessing examination quality in real time, these tools provide visual decision support for complex procedures such as ESD and POEM.

Innovation Never Stops. The Future Is Here.
We firmly believe that advances in technology, growing market demand, policy support, and investment will together drive the endoscopy industry toward an even brighter future.